Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973166649> ?p ?o ?g. }
- W2973166649 endingPage "51" @default.
- W2973166649 startingPage "44" @default.
- W2973166649 abstract "In opinion the Expert council provides management tactics for patients with hypertriglyceridemia (HTG). It is demonstrated that HTG is a common condition in overweight patients and is an important component of residual risk. HTG creates additional conditions for the progression of atherosclerosis, so the level of triglycerides (TG) is recommended to be measured in patients with a high, very high and extremely high risk level. An indication for the appointment of drugs that reduce the concentration of TG is its level of more than 2,3 mmol/L. Statins are the agents of choice to reduce the risk of cardiovascular disease in high-risk patients with hypercholesterolemia and HTG. Fenofibrate is used to correct HTG, and in case of intolerance to it or when the target level of TG is not reached, omega-3 ethers of polyunsaturated fatty acids in a dose of 2-4 g/day are recommended. In patients with HTG with a TG level >5,6 mmol/L, fenofibrate is the agent of choice." @default.
- W2973166649 created "2019-09-19" @default.
- W2973166649 creator A5001576884 @default.
- W2973166649 creator A5002838299 @default.
- W2973166649 creator A5003107578 @default.
- W2973166649 creator A5007079151 @default.
- W2973166649 creator A5009014954 @default.
- W2973166649 creator A5015006508 @default.
- W2973166649 creator A5017272996 @default.
- W2973166649 creator A5026090665 @default.
- W2973166649 creator A5029878354 @default.
- W2973166649 creator A5030212689 @default.
- W2973166649 creator A5032612237 @default.
- W2973166649 creator A5040976739 @default.
- W2973166649 creator A5042907601 @default.
- W2973166649 creator A5045169841 @default.
- W2973166649 creator A5045482135 @default.
- W2973166649 creator A5059361918 @default.
- W2973166649 creator A5060060724 @default.
- W2973166649 creator A5065574382 @default.
- W2973166649 creator A5066639107 @default.
- W2973166649 creator A5068468844 @default.
- W2973166649 creator A5072176403 @default.
- W2973166649 creator A5075358751 @default.
- W2973166649 creator A5082017706 @default.
- W2973166649 creator A5085386705 @default.
- W2973166649 creator A5087819631 @default.
- W2973166649 creator A5090421915 @default.
- W2973166649 date "2019-09-08" @default.
- W2973166649 modified "2023-10-14" @default.
- W2973166649 title "Correction of hypertriglyceridemia in order to reduce the residual risk in atherosclerosis-related diseases. Expert Council Opinion" @default.
- W2973166649 cites W1520609538 @default.
- W2973166649 cites W172350394 @default.
- W2973166649 cites W1954904400 @default.
- W2973166649 cites W1971911987 @default.
- W2973166649 cites W1974212760 @default.
- W2973166649 cites W1982040758 @default.
- W2973166649 cites W1989633984 @default.
- W2973166649 cites W2005965794 @default.
- W2973166649 cites W2018467496 @default.
- W2973166649 cites W2028933018 @default.
- W2973166649 cites W2034600674 @default.
- W2973166649 cites W2040433877 @default.
- W2973166649 cites W2040816046 @default.
- W2973166649 cites W2046891550 @default.
- W2973166649 cites W2057439678 @default.
- W2973166649 cites W2064150149 @default.
- W2973166649 cites W2093894290 @default.
- W2973166649 cites W2111099202 @default.
- W2973166649 cites W2116646125 @default.
- W2973166649 cites W2120934006 @default.
- W2973166649 cites W2125012558 @default.
- W2973166649 cites W2137739219 @default.
- W2973166649 cites W2144516660 @default.
- W2973166649 cites W2148352532 @default.
- W2973166649 cites W2150343380 @default.
- W2973166649 cites W2158057499 @default.
- W2973166649 cites W2160414137 @default.
- W2973166649 cites W2164089346 @default.
- W2973166649 cites W2164324917 @default.
- W2973166649 cites W2167067204 @default.
- W2973166649 cites W2169226612 @default.
- W2973166649 cites W2182460401 @default.
- W2973166649 cites W2195921894 @default.
- W2973166649 cites W2198678228 @default.
- W2973166649 cites W2899669642 @default.
- W2973166649 cites W4211109054 @default.
- W2973166649 cites W74840967 @default.
- W2973166649 doi "https://doi.org/10.15829/1560-4071-2019-9-44-51" @default.
- W2973166649 hasPublicationYear "2019" @default.
- W2973166649 type Work @default.
- W2973166649 sameAs 2973166649 @default.
- W2973166649 citedByCount "9" @default.
- W2973166649 countsByYear W29731666492020 @default.
- W2973166649 countsByYear W29731666492021 @default.
- W2973166649 countsByYear W29731666492022 @default.
- W2973166649 countsByYear W29731666492023 @default.
- W2973166649 crossrefType "journal-article" @default.
- W2973166649 hasAuthorship W2973166649A5001576884 @default.
- W2973166649 hasAuthorship W2973166649A5002838299 @default.
- W2973166649 hasAuthorship W2973166649A5003107578 @default.
- W2973166649 hasAuthorship W2973166649A5007079151 @default.
- W2973166649 hasAuthorship W2973166649A5009014954 @default.
- W2973166649 hasAuthorship W2973166649A5015006508 @default.
- W2973166649 hasAuthorship W2973166649A5017272996 @default.
- W2973166649 hasAuthorship W2973166649A5026090665 @default.
- W2973166649 hasAuthorship W2973166649A5029878354 @default.
- W2973166649 hasAuthorship W2973166649A5030212689 @default.
- W2973166649 hasAuthorship W2973166649A5032612237 @default.
- W2973166649 hasAuthorship W2973166649A5040976739 @default.
- W2973166649 hasAuthorship W2973166649A5042907601 @default.
- W2973166649 hasAuthorship W2973166649A5045169841 @default.
- W2973166649 hasAuthorship W2973166649A5045482135 @default.
- W2973166649 hasAuthorship W2973166649A5059361918 @default.
- W2973166649 hasAuthorship W2973166649A5060060724 @default.
- W2973166649 hasAuthorship W2973166649A5065574382 @default.
- W2973166649 hasAuthorship W2973166649A5066639107 @default.
- W2973166649 hasAuthorship W2973166649A5068468844 @default.